Skip to content

Teriparatide Injection in Osteoporotic Intertrochanteric Fractures for Improving Fracture Union

Effect of Three Months Daily Teriparatide Injection in Osteoporotic Intertrochanteric Fractures: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074479
Enrollment
60
Registered
2024-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M800- Age-related osteoporosis with current pathological fracture

Interventions

Intervention1: Daily subcutaneous 20 micro gm Teriparatide Injection for 3 months: Patients falling in the intervention group will receive daily subcutaneous 20 micro gm Teriparatide Injection for 3 m

Sponsors

Research Cell, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients above the age of 50 years presenting with Intertrochanteric fractures at Apex Trauma Centre, SGPGIMS and having established osteoporosis (T-Score of hip less than -2.5 on DEXA scan) and having been managed by operative intervention by PFN-A2 (Proximal Femoral Nail- Antirotation 2) and willing to participate in the study

Exclusion criteria

Exclusion criteria: Age less than 50 years BMD not falling within the osteoporotic range (T score of hip more than -2.5) Patients that were managed conservatively due to comorbidities Patients having contraindication to Teriparatide injection (like hypercalcemia, hyperparathyroidism, metabolic bone disease other than osteoporosis) Patients having any other bony fracture in the ipsilateral limb Patients having pre-existing hip disease Previous history of having taken Teriparatide or bisphosphonates or calcitonin or any hormonal therapy for osteoporosis within one year Patients not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
Fracture Union (based on RUSH (Radiographic Union Scale for Hip) score)Timepoint: 6, 12, 18 and 24 weeks. After that, they will be followed-up at 3 monthly intervals till 1 year.

Secondary

MeasureTime frame
Presence of any local or systemic complications, Change in Bone Mineral Density (BMD), Functional OutcomeTimepoint: 6, 12, 18 and 24 weeks. After that, they will be followed-up at 3 monthly intervals till 1 year.

Countries

India

Contacts

Public ContactKUMAR KESHAV

Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow

keshav4700@yahoo.co.in8400102266

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026